IL1B and breast cancer: Another study also showed that the expression of IL-1β by MICs in BC was significantly associated with longer relapse-free survival and overall survival, while the lack expression of IL-1β by MICs are associated with the worst prognosis, and may contribute to tumor immune escape [94].